The National Institute of Diabetes and Digestive and Kidney Diseases is funding research using radiographic imaging and artificial intelligence to evaluate liver cancer risk in patients with advanced liver disease. A portion of awarded funding will be used to acquire a clinical patient cohort, imaging datasets, and de-identified radiology reports from the University of Pennsylvania. The research aims to improve prediction of liver cancer risk, evaluate recurrence after curative therapy, and support translational research. The University of Pennsylvania will provide a clinical cohort of liver transplant patients with hepatocellular carcinoma, along with MRI studies, radiology reports, and clinical data. No specific timelines or budget amounts are mentioned, and the location for performance of services is the University of Pennsylvania.